Results 181 to 190 of about 157,469 (244)
<i>In Vitro</i> and <i>In Vivo</i> Evaluation of the Skincare Bioactivity of β-1,3;1,6-Glucans-Rich <i>Ganoderma lucidum</i> Polysaccharides. [PDF]
Huang CF +4 more
europepmc +1 more source
Chronic Pruritic Papular Eruption in an Elderly Man
JEADV Clinical Practice, EarlyView.
Filipe Monteiro +6 more
wiley +1 more source
ABSTRACT Background Non‐surgical treatment of the aging lower face remains a therapeutic challenge. Tissue Micro‐Coring Technology (MCT) is a novel technology that permits the non‐surgical removal of skin as micro‐cores, tightening skin and inducing collagen and elastin.
Omar A. Ibrahimi +3 more
wiley +1 more source
Bilateral eyelid erythema and oedema accompanied by systemic lupus erythematosus and syndrome of inappropriate antidiuretic hormone secretion. [PDF]
Goda K +7 more
europepmc +1 more source
Abstract Background As Parkinson's disease (PD) progresses, motor fluctuations become increasingly difficult to manage with oral medications. Foslevodopa/foscarbidopa (LDp/CDp), delivered as a continuous 24‐h/day subcutaneous infusion, offers continuous levodopa delivery and stable plasma levodopa levels that reduce motor fluctuations. LDp/CDp has been
K. Ray Chaudhuri +20 more
wiley +1 more source
Therapeutic synergy in long-standing plasma cell gingivitis: integrating photobiomodulation and immunomodulatory management. [PDF]
Hurtado J +3 more
europepmc +1 more source
Abstract Background Subcutaneous foslevodopa‐foscarbidopa (SCFF) is a novel, non‐surgical dopaminergic infusion therapy for better controlling motor fluctuations in advanced Parkinson's disease (PD). However, there are scarce real‐world data on efficacy, adverse events and comparisons with other infusion strategies. Objectives Here, we aimed to provide
Johannes Hartig +6 more
wiley +1 more source
Cutaneous Manifestations as a Sentinel of Colorectal Cancer: A Case Report. [PDF]
Marinho B, Velho G, Santos MD.
europepmc +1 more source
Abstract Background Non‐motor symptoms, especially autonomic dysfunction, are major contributors to disability and decreased quality of life in Parkinson's disease (PD). Despite being common and having a wide range of clinical facets, exocrine gland dysfunction is still not well recognized and managed.
Renato P. Munhoz +2 more
wiley +1 more source

